why choose us

First received: May 25, 2023

Clinical Trial: A Study to Learn About the Study Medicine PF-07853578 and How it Acts in the Bodies of Healthy Adults

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy Participants

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Randomized, Double-Blind, Sponsor-Open, Placebo-Controlled, Crossover, First-in-Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Oral Doses of PF-0

Brief Summary: The purposes of this study are:To see how the new medicine (PF-07853578) under study is tolerated.And if there are any important side effects.And, how people feel after taking single increasing amount of the medicine by mouth.To measure the amount of study medicine in your blood after the medicine is taken by mouth.This study is seeking for participants who:are females of 18 to 65 years old and are not able to give birth to a child.are males of 18 to 65 years old.have body mass index of 16 to 31 kilograms per…

Read more